Ozempic, Wegovy Maker Announces List Price Cut By Up To 50% For 2027

Ozempic, Wegovy Maker Announces List Price Cut By Up To 50% For 2027 This is the latest move in the ongoing war between weight loss drug rivals Novo Nordisk and Eli Lilly. Lowering the list price makes GLP-1 drugs more accessible for patients, including those who have high deductibles and those who pay coinsurance for medications. https://kffhealthnews.org/morning-breakout/ozempic-wegovy-maker-announces-list-price-cut-by-up-to-50-for-2027/